Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new page revision (v3.6.3) was published, replacing the previous revision (v3.6.0) and signaling an update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-06-30T01:36:39.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    New navigation/help sections were added: No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and a dedicated Intervention/Treatment section. The older heading style (Intervention / Treatment) was removed and the revision note updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T19:41:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a software update; the study content and details remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-08T16:53:42.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page displays a new Revision: v3.5.4, replacing the previous revision tag. This indicates a small, behind-the-scenes update to the page version rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:28.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s displayed revision/version indicator was updated from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-26T15:26:52.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Results have been posted for the study, with corresponding QC dates noted. A PDF of the Study Protocol and Statistical Analysis Plan has been added to Study Documents.
    Difference
    1%
    Check dated 2026-03-29T00:28:23.000Z thumbnail image

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.